AAPL333.69+3.37 (+1.02%) ▲|ABBV262.82+2.89 (+1.11%) ▲|ABT97.50+0.81 (+0.84%) ▲|ACN198.90-13.40 (-6.31%) ▼|ADBE237.69-3.59 (-1.49%) ▼|AMAT540.04+10.74 (+2.03%) ▲|AMD633.91+18.18 (+2.95%) ▲|AMGN403.04-4.23 (-1.04%) ▼|AMT162.20+1.14 (+0.71%) ▲|AMZN251.52+3.29 (+1.33%) ▲|AVGO355.14+11.50 (+3.35%) ▲|AXP302.78+0.69 (+0.23%) ▲|BA193.56+1.28 (+0.67%) ▲|BAC53.75+0.02 (+0.04%) ▲|BKNG159.02-1.26 (-0.79%) ▼|BLK1,059.63-4.73 (-0.44%) ▼|BMY61.15+0.32 (+0.53%) ▲|BNY145.40+1.48 (+1.03%) ▲|BRK-B502.65+2.15 (+0.43%) ▲|C128.50+1.50 (+1.18%) ▲|CAT845.42+19.07 (+2.31%) ▲|CL84.26-0.27 (-0.32%) ▼|CMCSA21.57-0.13 (-0.60%) ▼|COF194.72+0.24 (+0.12%) ▲|COP126.75-0.31 (-0.24%) ▼|COST920.65+5.71 (+0.62%) ▲|CRM234.69-2.00 (-0.85%) ▼|CSCO112.20+3.86 (+3.56%) ▲|CVS86.46+1.26 (+1.48%) ▲|CVX206.69-0.41 (-0.20%) ▼|DE687.00+19.74 (+2.96%) ▲|DHR214.06+2.30 (+1.09%) ▲|DIS102.19+0.86 (+0.85%) ▲|DUK114.13+0.39 (+0.34%) ▲|EMR161.61+3.04 (+1.92%) ▲|FDX290.36+3.29 (+1.15%) ▲|GD330.09-2.63 (-0.79%) ▼|GE309.56-2.83 (-0.91%) ▼|GEV988.70+1.25 (+0.13%) ▲|GILD144.74-2.76 (-1.87%) ▼|GM78.27-1.04 (-1.31%) ▼|GOOG340.35+5.42 (+1.62%) ▲|GOOGL343.50+5.26 (+1.56%) ▲|GS902.56+5.89 (+0.66%) ▲|HD282.85+0.39 (+0.14%) ▲|HON213.99+0.19 (+0.09%) ▲|IBM222.64-2.98 (-1.32%) ▼|INTC119.33-0.67 (-0.56%) ▼|INTU281.08-1.70 (-0.60%) ▼|ISRG391.95-9.29 (-2.32%) ▼|JNJ256.03-2.63 (-1.02%) ▼|JPM332.38-0.80 (-0.24%) ▼|KO85.65-0.45 (-0.52%) ▼|LIN479.48+10.03 (+2.14%) ▲|LLY1,142.85-7.00 (-0.61%) ▼|LMT505.41-0.09 (-0.02%) ▼|LOW180.80-1.58 (-0.87%) ▼|LRCX347.49+7.39 (+2.17%) ▲|MA552.26+2.26 (+0.41%) ▲|MCD231.89+0.06 (+0.03%) ▲|MDLZ58.19+0.43 (+0.74%) ▲|MDT86.38-0.06 (-0.07%) ▼|META728.08+2.15 (+0.30%) ▲|MMM161.89-1.13 (-0.69%) ▼|MO67.35+0.40 (+0.60%) ▲|MRK144.30+0.49 (+0.34%) ▲|MS190.31+2.30 (+1.22%) ▲|MSFT517.53+4.73 (+0.92%) ▲|MU1,074.89-22.50 (-2.05%) ▼|NEE76.83+0.48 (+0.63%) ▲|NFLX67.06-0.79 (-1.16%) ▼|NKE33.87-1.28 (-3.64%) ▼|NOW134.38-3.38 (-2.45%) ▼|NVDA233.95+3.09 (+1.34%) ▲|ORCL142.30+4.23 (+3.06%) ▲|PEP125.89+0.29 (+0.23%) ▲|PFE27.80-0.32 (-1.14%) ▼|PG144.91+0.96 (+0.67%) ▲|PLTR188.75-1.29 (-0.68%) ▼|PM187.46+0.88 (+0.47%) ▲|QCOM184.87+2.78 (+1.53%) ▲|RTX184.68-0.33 (-0.18%) ▼|SBUX94.71-0.17 (-0.18%) ▼|SCHW96.70-1.67 (-1.70%) ▼|SO83.72+0.25 (+0.30%) ▲|SPG200.95+0.14 (+0.07%) ▲|T24.30+0.00 (+0.00%) ▲|TMO654.80+2.29 (+0.35%) ▲|TMUS163.64+1.91 (+1.18%) ▲|TSLA370.59+16.48 (+4.65%) ▲|TXN293.80+12.49 (+4.44%) ▲|UBER68.11+0.23 (+0.34%) ▲|UNH371.90+6.70 (+1.83%) ▲|UNP278.28+5.86 (+2.15%) ▲|UPS93.02-0.87 (-0.93%) ▼|USB57.51+0.15 (+0.26%) ▲|V360.66+0.81 (+0.23%) ▲|VZ45.92-0.06 (-0.13%) ▼|WFC80.45+0.20 (+0.25%) ▲|WMT104.26+0.00 (+0.00%) ▲|XOM164.01+0.19 (+0.12%) ▲|AAPL333.69+3.37 (+1.02%) ▲|ABBV262.82+2.89 (+1.11%) ▲|ABT97.50+0.81 (+0.84%) ▲|ACN198.90-13.40 (-6.31%) ▼|ADBE237.69-3.59 (-1.49%) ▼|AMAT540.04+10.74 (+2.03%) ▲|AMD633.91+18.18 (+2.95%) ▲|AMGN403.04-4.23 (-1.04%) ▼|AMT162.20+1.14 (+0.71%) ▲|AMZN251.52+3.29 (+1.33%) ▲|AVGO355.14+11.50 (+3.35%) ▲|AXP302.78+0.69 (+0.23%) ▲|BA193.56+1.28 (+0.67%) ▲|BAC53.75+0.02 (+0.04%) ▲|BKNG159.02-1.26 (-0.79%) ▼|BLK1,059.63-4.73 (-0.44%) ▼|BMY61.15+0.32 (+0.53%) ▲|BNY145.40+1.48 (+1.03%) ▲|BRK-B502.65+2.15 (+0.43%) ▲|C128.50+1.50 (+1.18%) ▲|CAT845.42+19.07 (+2.31%) ▲|CL84.26-0.27 (-0.32%) ▼|CMCSA21.57-0.13 (-0.60%) ▼|COF194.72+0.24 (+0.12%) ▲|COP126.75-0.31 (-0.24%) ▼|COST920.65+5.71 (+0.62%) ▲|CRM234.69-2.00 (-0.85%) ▼|CSCO112.20+3.86 (+3.56%) ▲|CVS86.46+1.26 (+1.48%) ▲|CVX206.69-0.41 (-0.20%) ▼|DE687.00+19.74 (+2.96%) ▲|DHR214.06+2.30 (+1.09%) ▲|DIS102.19+0.86 (+0.85%) ▲|DUK114.13+0.39 (+0.34%) ▲|EMR161.61+3.04 (+1.92%) ▲|FDX290.36+3.29 (+1.15%) ▲|GD330.09-2.63 (-0.79%) ▼|GE309.56-2.83 (-0.91%) ▼|GEV988.70+1.25 (+0.13%) ▲|GILD144.74-2.76 (-1.87%) ▼|GM78.27-1.04 (-1.31%) ▼|GOOG340.35+5.42 (+1.62%) ▲|GOOGL343.50+5.26 (+1.56%) ▲|GS902.56+5.89 (+0.66%) ▲|HD282.85+0.39 (+0.14%) ▲|HON213.99+0.19 (+0.09%) ▲|IBM222.64-2.98 (-1.32%) ▼|INTC119.33-0.67 (-0.56%) ▼|INTU281.08-1.70 (-0.60%) ▼|ISRG391.95-9.29 (-2.32%) ▼|JNJ256.03-2.63 (-1.02%) ▼|JPM332.38-0.80 (-0.24%) ▼|KO85.65-0.45 (-0.52%) ▼|LIN479.48+10.03 (+2.14%) ▲|LLY1,142.85-7.00 (-0.61%) ▼|LMT505.41-0.09 (-0.02%) ▼|LOW180.80-1.58 (-0.87%) ▼|LRCX347.49+7.39 (+2.17%) ▲|MA552.26+2.26 (+0.41%) ▲|MCD231.89+0.06 (+0.03%) ▲|MDLZ58.19+0.43 (+0.74%) ▲|MDT86.38-0.06 (-0.07%) ▼|META728.08+2.15 (+0.30%) ▲|MMM161.89-1.13 (-0.69%) ▼|MO67.35+0.40 (+0.60%) ▲|MRK144.30+0.49 (+0.34%) ▲|MS190.31+2.30 (+1.22%) ▲|MSFT517.53+4.73 (+0.92%) ▲|MU1,074.89-22.50 (-2.05%) ▼|NEE76.83+0.48 (+0.63%) ▲|NFLX67.06-0.79 (-1.16%) ▼|NKE33.87-1.28 (-3.64%) ▼|NOW134.38-3.38 (-2.45%) ▼|NVDA233.95+3.09 (+1.34%) ▲|ORCL142.30+4.23 (+3.06%) ▲|PEP125.89+0.29 (+0.23%) ▲|PFE27.80-0.32 (-1.14%) ▼|PG144.91+0.96 (+0.67%) ▲|PLTR188.75-1.29 (-0.68%) ▼|PM187.46+0.88 (+0.47%) ▲|QCOM184.87+2.78 (+1.53%) ▲|RTX184.68-0.33 (-0.18%) ▼|SBUX94.71-0.17 (-0.18%) ▼|SCHW96.70-1.67 (-1.70%) ▼|SO83.72+0.25 (+0.30%) ▲|SPG200.95+0.14 (+0.07%) ▲|T24.30+0.00 (+0.00%) ▲|TMO654.80+2.29 (+0.35%) ▲|TMUS163.64+1.91 (+1.18%) ▲|TSLA370.59+16.48 (+4.65%) ▲|TXN293.80+12.49 (+4.44%) ▲|UBER68.11+0.23 (+0.34%) ▲|UNH371.90+6.70 (+1.83%) ▲|UNP278.28+5.86 (+2.15%) ▲|UPS93.02-0.87 (-0.93%) ▼|USB57.51+0.15 (+0.26%) ▲|V360.66+0.81 (+0.23%) ▲|VZ45.92-0.06 (-0.13%) ▼|WFC80.45+0.20 (+0.25%) ▲|WMT104.26+0.00 (+0.00%) ▲|XOM164.01+0.19 (+0.12%) ▲|
17 C
New York
Saturday, October 3, 2026

globenewswire

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield “Hits”. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies.

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DV

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Digimarc Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMRC

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline.

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

EBC Financial Group and Brokeree Solutions Forge Strategic Knowledge Partnership to Empower Global Trading Community

Collaboration combines trading expertise and technology to deliver smarter strategies, education, and tools for traders worldwide.

Snail Games 推出年度 Steam 发行商促销活动,提供创纪录折扣和全新内容更新

加利福尼亚州卡尔弗城, June 10, 2025 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq: SNAL,以下简称 “Snail Games” 或 “公司”) 将在 Steam 平台举办年度发行商促销活动,这是公司今年最具影响力的创收窗口之一。 活动期间,旗下全系列游戏均提供大幅折扣,多款备受期待的新游还将在 Steam Next Fest 期间开启前瞻试玩,充分展现 Snail 持续增长的势头与扩大玩家群体的强劲动力。

Snail Games 展開年度 Steam 發行商銷售活動,帶來破天荒折扣優惠及最新更新內容

加利福尼亞州卡爾弗城, June 10, 2025 (GLOBE NEWSWIRE) -- 全球領先的獨立互動數碼娛樂開發商與發行商 Snail, Inc. (Nasdaq: SNAL) (下稱「Snail Games」或「公司」),於 Steam 平台上舉辦年度發行商銷售活動,為該公司年度最具影響力的收益增長活動之一。 在 Steam Next Fest 舉行期間,Snail 旗下所有已發行的產品組合均會提供大幅折扣優惠,並為多款萬眾期待的遊戲推出預覽,該活動彰顯了公司的持續增長,以及透過其遊戲產品組合推動取得玩家的強勁勢頭。

BEN Reports First Quarter 2025 Results and Business Highlights

WILMINGTON, Del., June 09, 2025 (GLOBE NEWSWIRE) -- Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, today announced its results and key business highlights for the first quarter ended March 31, 2025.

Uniti Group Inc. Announces Pricing of Senior Notes Offering

LITTLE ROCK, Ark., June 09, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that its subsidiaries, Uniti Group LP, Uniti Fiber Holdings Inc., Uniti Group Finance 2019 Inc. and CSL Capital, LLC (together, the “issuers”), have priced their offering of $600 million aggregate principal amount of 8.625% Senior Unsecured Notes due 2032 (the “notes”). The notes will be issued at an issue price of 100.000%. The notes will be guaranteed on a senior unsecured basis by the Company and by each of its subsidiaries (other than the issuers) that guarantees indebtedness under the Company’s senior secured credit facility and the Company’s existing notes (except initially those subsidiaries that require regulatory approval prior to guaranteeing the notes). The offering is expected to close on June 24, 2025.

Fit Cafe Announces Official Website Update Featuring Natural Daily Supplement for Energy, Mood, and Metabolic Support

New U.S. Wellness Brand Launches Plant-Based Morning Supplement to Support Clean Energy, Mood, and Metabolism
New U.S. Wellness Brand Launches Plant-Based Morning Supplement to Support Clean Energy, Mood, and Metabolism

MetaMelt Announces Official Website Update Featuring Enhanced User Interface and Access to Metabolic Wellness Resources

New Daily Formula Designed to Naturally Support Metabolism, Energy, and Weight Wellness Without Stimulants
New Daily Formula Designed to Naturally Support Metabolism, Energy, and Weight Wellness Without Stimulants

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Civitas, Open Lending, and West Pharmaceutical and...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Compass Diversified (NYSE:CODI), Civitas Resources, Inc. (NYSE: CIVI), Open Lending Corporation (NASDAQ:LPRO), and West Pharmaceutical Services, Inc. (NYSE:WST). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and Avis Budget and...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ibotta, Inc. (NYSE:IBTA), NET Power, Inc. (NYSE:NPWR), Zenas BioPharma, Inc. (NASDAQ:ZBIO), and Avis Budget Group, Inc. (NASDAQ:CAR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

SOUNDHOUND ALERT: Bragar Eagel & Squire, P.C. is Investigating SoundHound AI, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SoundHound AI, Inc. (NASDAQ:SOUN) on behalf of long-term stockholders following a class action complaint that was filed against SoundHound on March 28, 2025 with a Class Period from May 10, 2024 and March 3, 2025. Our investigation concerns whether the board of directors of SoundHound have breached their fiduciary duties to the company.

- A word from our sponsors -

spot_img

Follow us